Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zeina Antoun

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Therapie|February 14, 2018
Céline Verstuyft, Zeina Antoun, Dominique Deplanque, et al.
Therapie|February 17, 2018
Céline Verstuyft, Zeina Antoun, Dominique Deplanque, et al.
Organic Letters|May 23, 2015
Stereoselective Rearrangement of (Trifluoromethyl)prolinols to Enantioenriched 3-Substituted 2-(Trifluoromethyl)piperidinesSarah Rioton, Aurélie Orliac, Zeina Antoun, et al.
Plos One|January 22, 2021
Management of acute COPD exacerbations in France: A qualitative survey in a private practice settingAnne Compagnon, Laurent Nguyen, Zeina Antoun, et al.
Journal of Patient Experience|December 19, 2022
Insights from Social Media on the Patient Experience of Living With Rare Eosinophil-Driven DiseasesMary Jo Strobel, Debbie Alves, Florence Roufosse, et al.
HIV Clinical Trials|February 11, 2003
Comparison of metabolic abnormalities and clinical lipodystrophy 48 weeks after switching from HAART to Trizivir versus continued HAART: the Trizal studyAlain Lafeuillade, Nathan Clumeck, Josep Mallolas, et al.
Antimicrobial Agents and Chemotherapy|October 15, 2008
Genotypic resistance analysis of the virological response to fosamprenavir-ritonavir in protease inhibitor-experienced patients in CONTEXT and TRIAD clinical trialsAnne-Geneviève Marcelin, Philippe Flandre, Jean-Michel Molina, et al.
Respiratory Medicine|July 29, 2018
Efficacy and safety of once-daily fluticasone furoate/vilanterol (FF/VI) versus twice-daily inhaled corticosteroids/long-acting β<sub>2</sub>-agonists (ICS/LABA) in patients with uncontrolled asthma: An open-label, randomized, controlled trialPhilippe Devillier, Marc Humbert, Alain Boye, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Therapie|February 14, 2018
Céline Verstuyft, Zeina Antoun, Dominique Deplanque, et al.
Therapie|February 17, 2018
Céline Verstuyft, Zeina Antoun, Dominique Deplanque, et al.
Organic Letters|May 23, 2015
Stereoselective Rearrangement of (Trifluoromethyl)prolinols to Enantioenriched 3-Substituted 2-(Trifluoromethyl)piperidinesSarah Rioton, Aurélie Orliac, Zeina Antoun, et al.
Plos One|January 22, 2021
Management of acute COPD exacerbations in France: A qualitative survey in a private practice settingAnne Compagnon, Laurent Nguyen, Zeina Antoun, et al.
Journal of Patient Experience|December 19, 2022
Insights from Social Media on the Patient Experience of Living With Rare Eosinophil-Driven DiseasesMary Jo Strobel, Debbie Alves, Florence Roufosse, et al.
HIV Clinical Trials|February 11, 2003
Comparison of metabolic abnormalities and clinical lipodystrophy 48 weeks after switching from HAART to Trizivir versus continued HAART: the Trizal studyAlain Lafeuillade, Nathan Clumeck, Josep Mallolas, et al.
Antimicrobial Agents and Chemotherapy|October 15, 2008
Genotypic resistance analysis of the virological response to fosamprenavir-ritonavir in protease inhibitor-experienced patients in CONTEXT and TRIAD clinical trialsAnne-Geneviève Marcelin, Philippe Flandre, Jean-Michel Molina, et al.
Respiratory Medicine|July 29, 2018
Efficacy and safety of once-daily fluticasone furoate/vilanterol (FF/VI) versus twice-daily inhaled corticosteroids/long-acting β<sub>2</sub>-agonists (ICS/LABA) in patients with uncontrolled asthma: An open-label, randomized, controlled trialPhilippe Devillier, Marc Humbert, Alain Boye, et al.
Pageof 1